| Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection J Eyquem, J Mansilla-Soto, T Giavridis, SJC van der Stegen, M Hamieh, ... Nature 543 (7643), 113-117, 2017 | 1795 | 2017 |
| Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial F Boulad, A Maggio, X Wang, P Moi, S Acuto, F Kogel, C Takpradit, ... Nature medicine 28 (1), 63-70, 2022 | 34 | 2022 |
| Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering A Odak, H Yuan, J Feucht, VA Cantu, J Mansilla-Soto, F Kogel, J Eyquem, ... Blood, The Journal of the American Society of Hematology 141 (22), 2698-2712, 2023 | 16 | 2023 |
| 274. One-step generation of universal CAR T Cells J Eyquem, J Mansilla-Soto, A Odak, M Sadelain Molecular Therapy 24, S109, 2016 | 7 | 2016 |
| Globin vector regulatory elements are active in early hematopoietic progenitor cells A Cabriolu, A Odak, L Zamparo, H Yuan, CS Leslie, M Sadelain Molecular Therapy 30 (6), 2199-2209, 2022 | 3 | 2022 |
| Targeted integration of a CAR at a novel genomic safe harbor directs potent therapeutic outcomes A Odak, H Yuan, J Feucht, J Mansilla-Soto, J Eyquem, C Leslie, ... Blood 136, 28, 2020 | 2 | 2020 |
| Novel Genomic Safe Harbors for Effective CAR T Cell Engineering A Odak, H Yuan, J Mansilla-Soto, J Eyquem, P Vedantam, C Leslie, ... Molecular Therapy 27 (4), 433-433, 2019 | 2 | 2019 |
| Circular RNA based Chimeric Antigen Receptor (CAR) Cell Therapy for potent and long-lasting anti-tumor activity Molecular Therapy 32 (4), 1 - 889, 2024 | | 2024 |
| Methods for identifying genomic safe harbors M Sadelain, A Odak US Patent App. 17/697,028, 2022 | | 2022 |
| Genomic safe harbors for transgene integration M Sadelain, A Odak US Patent App. 17/697,044, 2022 | | 2022 |
| A phase 1 trial of lentiviral globin gene therapy with reduced intensity conditioning in adults with transfusion dependent β-thalassemia F Boulad, A Maggio, X Wang, P Moi, S Acuto, F Kogel, C Takpradit, ... Nature medicine 28 (1), 63, 2022 | | 2022 |
| Erythroid Specificity and Safety of Globin-Encoding Lentiviral Vectors A Cabriolu, A Odak, F Kogel, M Sadelain Blood 136, 29, 2020 | | 2020 |
| Identification and Targeting of Novel Genomic Safe Harbors for Effective Human Gene Therapy A Odak Weill Medical College of Cornell University, 2020 | | 2020 |
| CRISPR/Cas9-Mediated Targeting of a CAR into the TRAC Locus Enhances CAR T Cell-Mediated Tumor Rejection J Mansilla-Soto, J Eyquem, T Giavridis, SJC van der Stegen, M Hamieh, ... MOLECULAR THERAPY 25 (5), 229-229, 2017 | | 2017 |
